参考文献/References:
[1]Saqib A,Sarwar MR,Sarfraz M,et al.Causality and preventability assessment of adverse drug events of antibiotics among inpatients having different lengths of hospital stay: a multicenter, cross-sectional study in Lahore, Pakistan[J].BMC Pharmacol Toxicol,2018,19(1):34.[2]Smyth RM,Gargon E,Kirkham J,et al.Adverse drug reactions in children-a systematic review[J].PLoS One,2012,7(3):e24061.[3]谢新鑫,杨青廷,旷满华,等.2004~2015年中国儿童抗生素使用情况分析[J].中南医学科学杂志,2016,44(2):130-134.[4]Barbieri E,Donà D,Cantarutti A,et al.Antibiotic prescriptions in acute otitis media and pharyngitis in Italian pediatric outpatients[J].Ital J Pediatr,2019,45(1):1-9.[5]Beck JN,Suppes SL,Smith CR,et al.Cost and potential avoidability of antibiotic-associated adverse drug reactions in children[J].J Pediatric Infect Dis Soc,2017,8(1):66-68.[6]Vieira JML,Matos GC,Silva FAB,et al.Serious adverse drug reactions and safety signals in children: a nationwide database study[J].Front Pharmacol,2020,11(2):964.[7]Alqenae FA,Steinke D,Keers RN.Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review[J].Drug Safety,2020,43(2):155-161.[8]McDonnell PJ,Jacobs MR.Hospital admissions resulting from preventable adverse drug reactions[J].Ann Pharmacother,2002,36(9):1331-1336.[9]Shoushtari AN,Friedman CF,Navid-Azarbaijani P,et al.Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma[J].JAMA Oncol,2018,4(1):98-101.[10]Gomm W,von Holt K,Thomé F,et al.Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis[J].JAMA Neurol,2016,73(4):410-416.[11]Brusselaers N,Lagergren J.The Charlson Comorbidity Index in Registry-based Research[J].Methods Inf Med,2017,56(5):401-406.[12]Gallagher RM,Kirkham JJ,Mason JR,et al.Development and inter-rater reliability of the liverpool adverse drug reaction causality assessment tool[J].PLoS One,2011,6(12):e28096.[13]Bracken LE,Nunn AJ,Kirkham JJ,et al.Development of the liverpool adverse drug reaction avoidability assessment tool[J].PLoS One,2017,12(1):e0169393.[14]Hartwig SC,Siegel J,Schneider PJ.Preventability and severity assessment in reporting adverse drug reactions[J].Am J Hosp Pharm,1992,49(9):2229-2232.[15]Dedefo MG,Mitike AH,Angamo MT.Incidence and determinants of medication errors and adverse drug events among hospitalized children in West Ethiopia[J].BMC Pediatr,2016,16(1):81.[16]马俊华.儿科临床上常见的不良药物反应及原因分析[J].中国现代药物应用,2013,7(9):118-119.[17]Amelung S.Association of preventable adverse drug events with inpatients’length of stay-A propensity-matched cohort study[J].Int J Clin Pract,2017,71(10).[18]王新宇,张艳仙,蒋睿,等.药物不良反应1055份报告分析[J].临床合理用药杂志,2021,14(7):141-142.[19]Saqib A,Sarwar MR,Sarfraz M,et al.Causality and preventability assessment of adverse drug events of antibiotics among inpatients having different lengths of hospital stay: a multicenter, cross-sectional study in Lahore,Pakistan[J].BMC Pharmacol Toxicol,2018,19(1):34.
相似文献/References:
[1]吴君华,吴友茹,李 丹.血清降钙素原在AECOPD抗感染治疗中的应用价值研究[J].医学信息,2018,31(02):74.[doi:10.3969/j.issn.1006-1959.2018.02.025]
WU Jun-hua,WU You-ru,LI Dan.Study on the Application Value of Serum Calcitonin in the Anti Infection Treatment of AECOPD[J].Medical Information,2018,31(20):74.[doi:10.3969/j.issn.1006-1959.2018.02.025]
[2]王晋蜀,黄梦雅,赵明丹,等.泌尿生殖道支原体感染检测、鉴定及耐药性分析[J].医学信息,2018,31(16):98.[doi:10.3969/j.issn.1006-1959.2018.16.029]
WANG Jin-shu,HUANG Meng-ya,ZHAO Ming-dan,et al.Detection,Identification and Drug Resistance Analysis of Urogenital Mycoplasma Infection[J].Medical Information,2018,31(20):98.[doi:10.3969/j.issn.1006-1959.2018.16.029]
[3]于文清.下呼吸道感染病原菌分布及耐药性分析[J].医学信息,2018,31(24):74.[doi:10.3969/j.issn.1006-1959.2018.24.019]
YU Wen-qing.Analysis of Distribution and Drug Resistance of Pathogenic Bacteria in Lower Respiratory Tract Infection[J].Medical Information,2018,31(20):74.[doi:10.3969/j.issn.1006-1959.2018.24.019]
[4]张佳佳,李 庆,王 同.中性粒细胞CD64指数指导慢性阻塞性肺疾病急性加重期抗生素应用的探讨[J].医学信息,2019,32(07):78.[doi:10.3969/j.issn.1006-1959.2019.07.023]
ZHANG Jia-jia,LI Qing,WANG Tong.The Application of Neutrophil CD64 Index in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Medical Information,2019,32(20):78.[doi:10.3969/j.issn.1006-1959.2019.07.023]
[5]叶志萍,宋 娇,荣 丹.抗宫炎胶囊联合抗生素对慢性宫颈炎患者的疗效及对T淋巴细胞亚群水平的影响[J].医学信息,2022,35(15):95.[doi:10.3969/j.issn.1006-1959.2022.15.021]
YE Zhi-ping,SONG Jiao,RONG Dan.Effect of Kanggongyan Capsule Combined with Antibiotics on T Lymphocyte Subsets in Patients with Chronic Cervicitis[J].Medical Information,2022,35(20):95.[doi:10.3969/j.issn.1006-1959.2022.15.021]
[6]宣恒报,成玉春,杨士军.医院感染的耐药菌分布特点与药物应用[J].医学信息,2019,32(22):114.[doi:10.3969/j.issn.1006-1959.2019.22.037]
XUAN Heng-bao,CHENG Yu-chun,YANG Shi-jun.Distribution Characteristics and Drug Application of Drug-resistant Bacteria in Nosocomial Infection[J].Medical Information,2019,32(20):114.[doi:10.3969/j.issn.1006-1959.2019.22.037]
[7]赵 培.抗生素降阶梯方案治疗小儿重症肺炎的有效性与安全性分析[J].医学信息,2020,33(03):146.[doi:10.3969/j.issn.1006-1959.2020.03.047]
ZHAO Pei.Effect of Antibiotic Step-down Protocol on Children with Severe Pneumonia[J].Medical Information,2020,33(20):146.[doi:10.3969/j.issn.1006-1959.2020.03.047]
[8]杨昌妮,李 宇,李晓芳,等.老年社区获得性肺炎诊治报道1例并文献复习[J].医学信息,2020,33(17):188.[doi:10.3969/j.issn.1006-1959.2020.17.059]
[9]邓智心,袁 莹,邹志玲,等.不孕症患者慢性子宫内膜炎的诊疗[J].医学信息,2021,34(11):31.[doi:10.3969/j.issn.1006-1959.2021.11.010]
DENG Zhi-xin,YUAN Ying,ZOU Zhi-ling,et al.Diagnosis and Treatment of Chronic Endometritis in Infertility Patients[J].Medical Information,2021,34(20):31.[doi:10.3969/j.issn.1006-1959.2021.11.010]
[10]周 瑞,张雪芬,张 宁,等.抗生素对早产儿肠道菌群影响的研究[J].医学信息,2023,36(03):177.[doi:10.3969/j.issn.1006-1959.2023.03.039]
ZHOU Rui,ZHANG Xue-fen,ZHANG Ning,et al.Effect of Antibiotics on Intestinal Microflora in Premature Infants[J].Medical Information,2023,36(20):177.[doi:10.3969/j.issn.1006-1959.2023.03.039]